Tatiana Cunha Pereira Rita Rb-Silva Rita Félix Soares Nelson Domingues José Mariz
10.12688/f1000research.24816.2
F1000Res
2020 Jul 8;9:687.
brentuximab-vedotin c neoformans hodgkin lymphoma meningitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/33024550/
Brentuximab Vedotin / therapeutic use Hodgkin Disease / complications Hodgkin Disease / drug therapy Meningitis, Cryptococcal / drug therapy
Brentuximab Vedotin / therapeutic use Hodgkin Disease / complications Hodgkin Disease / drug therapy Meningitis, Cryptococcal / drug therapy Case Reports Amphotericin B / therapeutic use Antifungal Agents / therapeutic use Cryptococcus neoformans Dexamethasone / therapeutic use Flucytosine / therapeutic use Humans Male Middle Aged Opportunistic Infections / drug therapy Opportunistic Infections / microbiology Antifungal Agents Dexamethasone Brentuximab Vedotin Amphotericin B Flucytosine
PMC7512028
33024550
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy
2020